ArticlePloS one2025
The association between the C-reactive protein-triglyceride-glucose index and cardiovascular diseases: A cohort study using data from the China Health and Retirement Longitudinal Study 2011-2020.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Associations of the combined C-reactive protein-triglyceride glucose index and frailty index in different dimensions with incident stroke among individuals with stages 0-3 cardiovascular-kidney-metabolic syndrome.Cardiovascular diabetology · 2026Article
- Associations of the uric acid-to-high-density lipoprotein cholesterol ratio with hypertension: a cross-sectional study from the China health and retirement longitudinal study.Scientific reports · 2026Article
- Metabolic status modifies the predictive value of the C-reactive protein-triglyceride-glucose Index-waist-to-height ratio for major adverse cardiovascular and cerebrovascular events: a prospective cohort study from the China Health and Retirement Longitudinal Study (CHARLS).Cardiovascular diabetology · 2026Article
- Article
- Association of the C-reactive protein-triglyceride-glucose index with the risk of incident cardiovascular disease in rectal cancer survivors.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInflammation and insulin resistance (IR) are both risk factors for cardiovascular disease (CVD). The C-reactive protein-triglyceride-glucose index (CTI) is a novel biomarker that comprehensively assesses the severity of inflammation and IR. This study investigates the association between CTI and the risk of CVD.
methodsData from the China Health and Retirement Longitudinal Study (CHARLS) conducted between 2011 and 2020 were utilized, focusing on individuals aged 45 years and older. The CTI was calculated as 0.412 × Ln (C-reactive protein [CRP, mg/L]) + Ln (triglycerides [TG, mg/dL] × fasting blood glucose [FBG, mg/dL]/ 2). Self-reported CVD events were used as the primary outcome measure. Multivariable Cox regression, restricted cubic splines (RCS) analysis, and subgroup analyses were performed to examine the association between CTI and CVD risk.
resultsThis study included 5,642 participants, with a CVD incidence rate of 23.70% (1,337 cases). After adjusting for covariates, each unit increase in the CTI was associated with an 11% increase in the risk of CVD (hazard ratio (HR) = 1.11, 95% confidence interval (CI) = 1.01-1.23). Similar results were observed when CTI was analyzed as a categorical variable (quartiles). RCS analyses revealed a nonlinear relationship between CTI and CVD risk. Subgroup analysis revealed no significant associations in certain subgroups, suggesting that the effect of the association may be heterogeneous.
conclusionHigher CTI (whether treated as a continuous or categorical variable) was significantly associated with an increased risk of CVD. A nonlinear relationship between CTI and CVD risk was observed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.